The consumption of analgesic medicine in Spain has shown a consistent upward trend from 2013 to 2023, with the value standing at 76.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2023. Analyzing the year-on-year variations, we see a notable peak in growth rates, particularly in 2020 (7.98%) and 2022 (8.62%). The Compound Annual Growth Rate (CAGR) over the last five years stands at 7.53%, indicating a robust increase in usage.
Looking forward to the forecasted period from 2024 to 2028, the CAGR is expected to slow down to 4.86%, but overall usage is still anticipated to grow by 26.81%, reaching 103.6 by 2028. The slower but steady growth suggests market maturity and perhaps saturation in the coming years.
Future trends to watch for:
- Impact of new healthcare policies and regulations on analgesic prescription practices.
- Potential market shifts due to emerging alternative pain management therapies.
- Public health campaigns aimed at reducing over-reliance on analgesics and promoting non-pharmacological pain management options.
- Technological advancements in drug delivery systems that could influence consumption patterns.
- Socio-demographic changes, such as aging population, which might sustain or even increase the demand for analgesics.
